Table 2.
Treatment, follow-up duration, and adverse events
| Patient no. | Treatments associated with azithromycin | Azithromycin treatment duration (months) | Follow-up without azithromycin (months) | Adverse event |
|---|---|---|---|---|
| 1 |
LH |
6 |
8 |
|
| 2 |
LH |
4 |
9 |
|
| 3 |
LH |
6 |
12 |
Moderate ocular redness upon instillation |
| 4 |
LH, topical cyclosporine added at month 5 for 5 months |
10 |
11 |
Important burning, treatments stopped at month 10 |
| 5 |
LH |
6 |
9 |
Mild stinging upon instillation |
| 6 |
LH |
5 |
13 |
|
| 7 |
LH |
6 |
9 |
|
| 8 |
LH |
8 |
12 |
|
| 9 |
LH |
4 |
10 |
Mild stinging upon instillation |
| 10 |
LH |
6 |
11 |
|
| 11 |
LH |
6 |
9 |
|
| 12 |
LH |
6 |
12 |
Moderate ocular redness upon instillation |
| 13 |
LH |
6 |
10 |
|
| 14 |
LH |
6 |
11 |
|
| 15 |
LH |
6 |
12 |
|
| 16 | LH | 5 | 14 | Important burning, treatment stopped at month 5 |
LH, lid hygiene.